Protein phosphorylation cascades play a central role in the regulation of cell growth and protein 24 kinases PKA, Sch9 and Ypk1 take centre stage in regulating this process in S. cerevisiae. To 25 understand how these kinases co-ordinately regulate cellular functions we compared the 26 phospho-proteome of exponentially growing cells without and with acute chemical inhibition of 27 PKA, Sch9 and Ypk1. Sites hypo-phosphorylated upon PKA and Sch9 inhibition were preferentially 28 located in RRxS/T-motifs suggesting that many are directly phosphorylated by these enzymes.
ABSTRACT 23
Protein phosphorylation cascades play a central role in the regulation of cell growth and protein 24 kinases PKA, Sch9 and Ypk1 take centre stage in regulating this process in S. cerevisiae. To 25 understand how these kinases co-ordinately regulate cellular functions we compared the 26 phospho-proteome of exponentially growing cells without and with acute chemical inhibition of 27 PKA, Sch9 and Ypk1. Sites hypo-phosphorylated upon PKA and Sch9 inhibition were preferentially 28 located in RRxS/T-motifs suggesting that many are directly phosphorylated by these enzymes. 29 Interestingly, when inhibiting Ypk1 we not only detected several hypo-phosphorylated sites in the 30 previously reported RxRxxS/T-, but also in an RRxS/T-motif. Validation experiments revealed that 31 neutral trehalase Nth1, a known PKA target, is additionally phosphorylated and activated 32 downstream of Ypk1. Signalling through Ypk1 is therefore more closely related to PKA-and Sch9-33 signalling than previously appreciated and may perform functions previously only attributed to 34 the latter kinases. Cell growth is dynamic and highly regulated by signalling pathways that are conserved across 2 evolution. To accomplish this regulation, eukaryotes have developed intricate means to assess 3 growth conditions and to rapidly communicate this information to the processes controlling the 4 accumulation of mass, the modification of cellular volume and of membrane surface area. Although 5 many signal transduction pathways are involved in this regulation, those employing AGC-family 6 kinases (named after Protein Kinases A, G and C) are prominent. 7
The target of rapamycin complexes 1 and 2 (TORC1 and TORC2) are central sensors of environmental 8 conditions and regulators of cell growth (1) . Both complexes exert their functions by 9
phosphorylating AGC-kinases as their main targets. In S. cerevisiae TORC1 primarily responds to 10 changes in carbon and nitrogen availability and regulates ribosome biogenesis, cell cycle progression 11 and stress responses via the AGC-kinase Sch9, similar to S6K downstream of mammalian TORC1 12 (1, 2) . 13
Another AGC-kinase, protein kinase A (PKA), performs many, if not most of its functions in parallel to 14 Sch9 by regulating an overlapping set of functions and potentially by cross-talk (3) (4) (5) . Indeed, Sch9 15 was originally identified by virtue of its ability to suppress growth phenotypes associated with loss of 16 PKA activity (6) . Reciprocally, hyper-activation of PKA signalling can suppress phenotypes linked to 17 the loss of Sch9 activity (4). 18 Tpk1, Tpk2 and Tpk3 are the partially redundant paralogs of the catalytic subunit of PKA. When cells 19
are starved of carbon, cyclic AMP (cAMP) levels are low and, as a consequence, PKA is kept inactive 20 by its regulatory subunit Bcy1. Glucose addition induces activation of the adenylate cyclase 21
Cyr1/Cdc35 via the small GTPase Ras1/2 and the G protein-coupled receptor Gpr1. The subsequent 22 increase in cAMP levels triggers the dissociation of Bcy1 from the Tpks allowing them to 23 phosphorylate their substrates (7, 8) . Additionally, cAMP-independent activation of PKA has been 24 reported (9). In addition to cell growth, Tpk effectors influence many other processes including 25 carbohydrate metabolism, cell cycle progression, sporulation, pseudohyphal development and 26 longevity by controlling the activities of metabolic enzymes, transcription and autophagy factors 27 (10) (11) (12) (13) . 28 Similarly to TORC1, TORC2 phosphorylates and activates AGC-kinases, including Ypk1 and its 29 redundant paralog Ypk2, in their hydrophobic motif (14, 15) . Deletion of YPK2 produces no obvious 30 phenotype suggesting that it only plays a minor role in cell growth control (16) . Recent work has 31 demonstrated that TORC2 is regulated downstream of membrane tension (17) , oxidative stress (18) 32 and carbon cues (19) . In turn, Ypk1, which is homologous to the mTORC2 substrate SGK in humans, 33 couples TORC2 signals to the regulation of membrane lipid biosynthesis and the regulation of cell 34 surface area (20, 21) . 35 Despite their central role in the regulation of fundamental cellular processes and intense efforts in 36 understanding the functions controlled by these kinases, a systematic assessment of their targets 37 has been lacking to date. A previous study aimed at systematically defining changes in the phospho-38 proteome associated with the absence of protein kinases, using kinase deletion strains (22) . 39 However, this approach is limited to the study of non-essential kinases and allows cells to adapt to 40 the absence of a kinase. 41
To overcome these limitations, we employed yeast strains expressing analog-sensitive (23) variants 42 of PKA, Sch9 and Ypk1. Mutation of the gatekeeper residue of these kinases allows binding of the 43 bulky ATP-analog C3-1'-naphthyl-methyl PP1 (1NM-PP1), thus preventing ATP-binding and rendering 44 the enzymes inactive. Using this selective and acute way of kinase inhibition, we explored the 45 phospho-protein targets downstream of each of these major AGC-kinases by means of quantitative 46 1 new targets of each tested kinase. As expected, we found extensive substrate overlap between PKA 2 and Sch9. Unexpected was our finding that several substrates were shared between PKA and/or 3
Sch9 and Ypk1 and that many sites hypo-phosphorylated upon Ypk1 inhibition resided in an RRxS/T-4 motif, which has previously been associated with PKA and Sch9, rather than Ypk1. 5
Among the numerous potentially new kinase-substrate relationships discovered in this study, we 6 chose neutral trehalase Nth1 as a candidate for follow-up experiments. Nth1 has been employed as 7 a model PKA-substrate in multiple previous studies (24, 25) . Trehalose is a disaccharide that functions 8
as a stress-protectant and reserve carbohydrate under adverse conditions (26, 27) . Upon return to 9 favourable conditions, trehalose is converted into two molecules of glucose by trehalases, including 10 the neutral trehalase Nth1 (25, 28) . The regulation of Nth1 by PKA has long been recognized as 11 important for cell survival (24, 29) . Here, we site-specifically validated that Ypk1-, as well as PKA-12 inhibition reduced its phosphorylation of an RRxS-site and showed that this is associated with 13 reduced trehalase activity. 14 These findings highlight the need for revisiting the Ypk1 consensus motif and prompt further 15 investigation of the relationship of PKA and TORC1-Sch9 signalling on one hand and the TORC2-Ypk1 16
pathway on the other hand. 17
18

RESULTS
19
Evaluation of the chemical genetics approach for the analysis of S. cerevisiae AGC-20 kinases 21 To study substrate specificities and potential signal convergence of growth-regulatory AGC-kinases 22 we used quantitative mass spectrometry to determine changes in the yeast phospho-proteome after 23 acute inhibition of Sch9, PKA or Ypk1. As overlapping functions of PKA and Sch9 have been reported 24 (3, 6) , we also performed simultaneous inhibition of PKA+Sch9. Genes encoding wt kinases were 25 replaced with alleles encoding the corresponding analog-sensitive enzymes (34). In the pka as strains 26 all three PKA-paralogs (TPK1, TPK2, TPK3) were replaced with analog-sensitive alleles. The YPK1 27
paralog YPK2, which is considered to play a minor role compared to YPK1 (16) , was deleted in all 28 strains to avoid redundancy. S. cerevisiae strains with analog-sensitive Ypk1 (18), Sch9 (30) and PKA 29 (31) have been used successfully in previous studies. 30 We characterized these analog-sensitive strains (denoted as sch9 as , pka as , ypk1 as and pka as +sch9 as ) 31
versus the isogenic background (referred to as wt as ) by assessing their growth on plates with and 32 without ATP-analog ( Fig. 1 and Fig. S1 ). Given the central role of all three kinases in growth 33 regulation, we expected visible effects on colony size upon the inhibition of any of them. A slight 34 reduction of colony size was observed for the sch9 as and pka as +sch9 as strains even on plates without 35 1NM-PP1, indicating that these strains were mildly hypomorphic. The strongest effect of kinase 36 inhibition was seen in case of the pka as +sch9 as strain, which did not form colonies on plates 37
containing 500 nM 1NM-PP1. Inhibition of Sch9 alone also exhibited a visible reduction in growth. 38
Interestingly, a small number of regular-sized colonies formed under these conditions, indicating 39 that a limited number of cells adapted or became insensitive to Sch9-inhibition. This is consistent 40 with a previous observation in our lab of an sch9Δ-strain rapidly generating adapted clones (32) . 41
While less pronounced than for Sch9, the inhibition of Ypk1 also had a strong effect on colony 42 formation on plates.
43
In contrast, the presence of 1NM-PP1 only mildly compromised colony size in case of the pka as 44 strain. Therefore, the analog-dependent inhibition of pka as is either less efficient than for sch9 as and 45 ypk1 as or the absence of PKA activity is compensated by other pathways in our strain background. 46
This second alternative seems unlikely in light of the observation that tpk1Δ tpk2Δ tpk3Δ triple-1 deletion strains are not viable (6, 8, 16) . It can be envisioned, however, that there is an increased 2 likelihood of an adaptive response upon prolonged exposure of an analog-sensitive strain to ATP-3 analog than during creation of a deletion strain . Nevertheless, the comparison of the 1NM-PP1  4 treated sch9 as and pka as +sch9 as strain demonstrated that pka as is sensitive to 1NM-PP1 (Fig.1 and Fig.  5 S1) and this finding further suggested that the compensation for PKA function is mainly through 6
Sch9, which is consistent with previous findings (see Broach, 2012 for a review). For phospho-proteome analyses, analog-sensitive strains treated with 1NM-PP1 vs. DMSO were 15 compared by label-free, quantitative shotgun proteomics. 16 At a false-discovery rate (FDR) of 0.01, 7575 peptides, 4628 of which were phosphorylated (61%), 17 were identified from phospho-peptide enriched samples from the respective strains. These 18 phospho-peptides corresponded to 6373 phospho-sites (at site-decoy fraction: 0.01), mapping to 19 1430 proteins. 20 Out of the 4628 identified phospho-peptides, 3113 had no more than one missing value in three 21 replicates of any sample and were thus considered for further analysis (Tab. S1). At a multiple-22 testing corrected p-value cut-off (pAdj) of 0.05, 439 phospho-peptides were found to be altered in 23 their abundance upon 1NM-PP1 treatment in the Ypk1-, 128 in the Sch9-, 118 in the PKA-and 293 in 24 the PKA+Sch9 dataset (i.e. 2.5-9.5% of phospho-peptides were altered in the datasets). For 25 comparison, 12 phospho-peptides were classified as changing when wt as cells were treated with the 26 ATP-analog, corresponding to a 0.4% false-positive rate. 27 28 Principal component analysis of these data revealed that replicate samples clustered and that 29 separation of samples was mainly explained by genotype rather than by treatment ( Fig. S2 ). While 30 the pka as strain was localized near wt as , the ypk1 as strain on one hand and sch9 as and pka as +sch9 as 31 strains on the other formed separate clusters. 32 With respect to the sch9 as and pka as +sch9 as strains this result is consistent with the observed 33 reduced colony size of these strains obtained in a spot assay in the absence of 1NM-PP1 ( Fig. 1 and 34 Fig. S1 ). This suggests that the gatekeeper mutations in Sch9 and Ypk1 reduce the catalytic activity of 35 these kinases and render the strains hypomorphic. In contrast, we did not observe impaired colony 36 formation of the ypk1 as strain. This indicates that the extent of reduced phosphorylation of Ypk1 1 targets in this strain is not sufficient to lead to an observable proliferation phenotype. 2 A heatmap depicting the intensity fold changes of peptides significantly (pAdj < 0.05) hypo-or hyper-3 phosphorylated upon kinase inhibition is shown in Fig. S3 . This global overview suggests a similar 4 pattern of changes in the PKA+Sch9, Sch9 and PKA datasets, albeit for some phospho-peptides 5 changes are only apparent in the PKA+Sch9 dataset. In contrast, the Ypk1 dataset contains some 6
phospho-peptides which change in the same direction as in one or more of the other datasets, but 7 the majority appears to change uniquely in this sample. 8 9
To further assess the commonalities and differences between the inhibition of these kinases we 10 determined the overlap among significantly (pAdj < 0.05) altered phospho-peptides observed for each 11 strain tested. 12
We first asked whether our data would recapitulate the previously reported interaction between 13 PKA and Sch9 signalling in the form of shared targets (3) . Indeed, one third to one half of the 14 phospho-peptides significantly affected (i.e. hyper-or hypo-phosphorylated) in one of the datasets 15 was also significant in the other (50 out of 117 and 128 respectively). This may indicate a strong 16 overlap of or cross-talk between the signalling pathways. In the former case it can be envisioned that 17
for some shared targets the inhibition of one of the inputs is compensated by the other. An 18 argument in favour of this proposition is the finding that approximately twice as many significant 19 phospho-peptides (293) were identified in the PKA+Sch9 dataset compared to the individual PKA and 20
Sch9 datasets. Furthermore, 112 of these were unique to the PKA+Sch9 dataset, consistent with the 21 notion that wild type PKA or Sch9 masks the loss of the other for many targets. On the other hand, 22
80% of the Sch9-and 66% of the PKA-targets were significantly altered also in the PKA+Sch9 dataset, 23 arguing that the high number of sites unique to PKA+Sch9 is not merely due failure to detect true 24 positives repeatedly over datasets. 25 We next addressed the overlap between PKA/Sch9-and Ypk1-targets, which we expected to be low 26 as TORC2-signalling is considered to be less connected to PKA-and Sch9-signalling than the latter 27 two to each other. Consistent with this idea, we found 297 phospho-peptides uniquely affected by 28
Ypk1 inhibition. Surprisingly, 142 phospho-peptides (32%) were shared with at least one other 29 dataset, especially with PKA+Sch9 (27%). 30
The results were qualitatively similar when focussing only on hyper-( Fig. S4B ) and hypo-31 phosphorylated ( Fig. S4C ) phospho-peptides, in that targets unique to the Ypk1-and PKA+Sch9-32 datasets constituted the largest groups while a strong prevalence of phospho-peptides shared 33 between sets was also apparent. 34 35 A full list of gene ontology (GO) terms significantly enriched (p < 0.05) among proteins with 36 regulated phospho-sites is given in Tab. S2. Among the Biological Process GO terms, 'endocytosis', 37
which was enriched in the Ypk1-dataset, is a major downstream process regulated by this kinase 38 (33). Indeed, the majority of the 65 proteins associated with this term form an interconnected 39 network with Ypk1 that contains key proteins from several stages of endocytosis (initiation: Syp1, 40
Ede1; budding: Pan1, Las17, Ent1, Ent2; and coat disassembly: Inp52) ( Fig. S5 )(34). It should be noted 41 that many of these proteins likely are not direct Ypk1 targets, but connected further downstream in 42
the Ypk1-Fpk1-Dnf1/Dnf2-Akl1 axis ( Fig. S5 ) (34). Beyond these fundamental endocytic steps, 43 proteins involved in cargo recruitment (Bul1, Ecm21, Rod1, Aly1 and Aly2) were also found to be 44 affected by Ypk1 inhibition. Interestingly, the nutrient permease regulator Npr1 forms part of this 45 network, even though it previously had been associated with TORC1 rather than TORC2 signalling 46 (35) . 47
'Regulation of transcription involved in meiotic cell cycle' and 'Response to abiotic stimulus' were 48 both enriched in the PKA-, while no significant terms were found for the Sch9-and PKA+Sch9-49 datasets. 50
Similar gene ontologies related to transferase/glucosyltransferase activity were detected for the 51 PKA, Sch9 and PKA+Sch9 dataset and the proteins associated with these GO-terms in the three 1 datasets strongly overlapped and included subunits of the trehalose 6-phosphate/phosphatase 2 complex (Tsl1 and Tps3), glycogen phosphorylase Gph1 and glycogen synthases Gsy1 and Gsy2 (Tab.  3 S2). The fact that both homologs Gsy1 and Gsy2 were detected based on distinct peptides lends 4
validity to the finding that the regulation of storage carbohydrate metabolism is an important 5 function of PKA and Sch9 signalling (Tab. S1). Additionally, the neutral trehalase Nth1 was found to 6 be affected by PKA and Ypk1 inhibition (see below). 7 8 In summary, we observed that all the analog-sensitive kinases were affected by 1NM-PP1 addition 9
based on the growth of the corresponding strains and on observed changes in protein 10 phosphorylation. These phosphorylation changes are consistent with previous knowledge, especially 11 with respect to the close connection between PKA-and Sch9-signalling. Additionally, enriched GO-12 terms reflect previous data, but are represented also by additional proteins that had not been linked 13
to the respective kinases. 14 15
Sequence motifs 16 To determine if AGC-kinases in our experiments preferentially targeted specific amino acid 17 sequences, we generated logos of the sequences surrounding phospho-sites significantly affected by 18
1NM-PP1 treatment. This was done individually for up-and down-regulated sites and for a 19 combination of both for each of the four datasets ( Fig. 2 ). 20 21 A clear enrichment of arginines in the -2 and -3 position of residues hypo-phosphorylated upon the 22
inhibition of any of the kinases was observed. The motifs of the PKA, Sch9 and PKA+Sch9 datasets 23 closely resembled each other in this respect and exhibited stronger enrichment of arginine in the -2 24 than -3 position. These findings are consistent with the reported RRxS/T consensus motif for PKA 25 and Sch9 and may therefore reflect the presence of direct targets of the studied kinases (36,37). 26
For hypo-phosphorylated sites in the Ypk1-dataset in contrast, arginine was more strongly enriched 27 in the -3 position and further enrichment of arginines N-terminal of the phosphorylated residue, in 28 particular at -5 and -2, could be observed. The sequence context determined for Ypk1 fitted the 29
reported RxRxxS/T-motif due to the enrichment of arginine in the -5 and -3 position (38), however 30
additionally an unexpectedly high frequency of arginine in the -4 and especially -2 position was 31 apparent in our data . 32 33 It is noteworthy that a slight enrichment of arginine in the -3 position of sites hyper-phosphorylated 34 upon kinase inhibition was observable. As the change in abundance was opposite to what was 35 expected for direct targets, it is possible that this residue forms part of the recognition sequence of a 36 kinase that is itself repressed by the analog-sensitive kinases studied. 37
In each case, the PKA+Sch9 motifs constituted a more pronounced version of the PKA and Sch9 38 motifs, therefore indicating that Sch9-and PKA-signalling converge either through shared targets or 39 cross-talk. horizontal lines indicate over-and underrepresentation at p = 0.05. 6 7 Phosphorylation levels of known direct AGC kinase targets 8 To estimate if our approach was suitable to identify direct AGC-kinase targets we asked how many of 9 their previously known target-sites were identified and exhibited significant down-regulation upon 10 kinase inhibition in our dataset. Ypk1, Sch9 and PKA target sites derived from the literature are listed 11
in tables S3A-C. 12
While only 14% to 19% of bona fide kinase target sites were detected (i.e. identified and quantified) 13 by mass spectrometry, the vast majority of these sites were significantly hypo-phosphorylated upon 14 inhibition of the respective kinase: 15
Three of the 21 known Ypk1 target sites were detected in this study and all found to be down- 16 regulated upon Ypk1-inhibition (Lag1 S24, Gpd1 S24, Rod1 S138; Fig. S6A ). Similarly, two of the 13 17 known Sch9 target sites were detected here and both were down-regulated in the Sch9 and the 18
PKA+Sch9 datasets (Stb3 S254, Maf1 S90; Fig. S6B ). Finally, six of 31 bona fide PKA-sites were 19 detected and three of them were down-regulated in the PKA (Bcy1 S145, Nth1 S60, Nth1 S83) and 20 six in the PKA+Sch9 (Bcy1 S145, Nth1 S60, Nth1 S83, Maf1 S90, Pat1 S456 and Pat1 S457) dataset 21 (Fig. S6C ). 22
Therefore, while our phospho-proteomics data suffered from the high false negative rate with 23 respect to detection, typically associated with this approach, the quantitative accuracy appeared 24 sufficient to detect biologically meaningful changes. 25
Many proteins possess more than one regulated phospho-site 26 Several of the previously reported AGC-kinase targets (e.g. Fpk1, Orm1, Fps1, Stb3, Maf1 and Rim15) 27 harbour more than one regulated phospho-site (Tab. S3A-C) (39) (40) (41) (42) (43) (44) . We therefore asked if this 28 feature could also be observed in our study. Site-specific quantification of phosphorylation levels can 29 be complicated by several sites residing on the same phospho-peptide as it may not be clear which 30 site is responsible for an observed change in phospho-peptide abundance. Furthermore, sites 1 located near lysine or arginine may impede tryptic cleavage and distort the quantification of nearby 2 residues. We therefore used the presence of arginine in the -3 position from the phosphorylated 3 residue, which is a frequent feature of target sites of the AGC-kinases under investigation, as an 4
additional criterion for selecting proteins with multiple regulated sites (21, 45) . 5 Notable observations included the detection of two regulated RxxS-sites on the previously reported 6
Sch9-target Stb3 in the Sch9 and PKA+Sch9 datasets (42) . We also observed two and three regulated 7
phospho-sites on the protein kinase Ksp1 in the Sch9 and PKA+Sch9 datasets respectively, one of 8 which (S624) was also significant in the Ypk1 dataset. Additionally, S884-phosphorylation on this 9
protein was only affected upon Ypk1-inhibition. In the Ypk1 dataset, only a few of the RxxS/T-sites 10 on multi-site proteins were found in the strict RxRxxS/T-motif ascribed to Ypk1 (45). Instead, several 11 of the multi-site proteins were shared with other datasets, including Smy2, Gcs1, Igo2, Ksp1 and 12
Avt1 (Tab. S1). 13
Similarly, several of the regulated RxxS/T-sites on multi-site proteins in the PKA dataset were found 14 in relaxed motifs, i.e. without a basic residue in the -2 position, but with a proline at +1 (T70 and S96 15 on Smy2; T161 and T170 on Gcs1; S135, S147 and S161 in Tsl1). Interestingly, four regulated 16
phospho-sites were detected on the trehalose synthase subunit Tsl1 in all four datasets. 17 Finally, three RxxS phospho-sites on Bcy1 were significantly affected in the PKA and PKA+Sch9 18
datasets. Phospho-peptides containing either S83 or S145 exhibited an ~45%-75% reduced 19
abundance upon kinase inhibition in both datasets, while phospho-peptides with T129 showed an up 20
to two-fold increase in the PKA dataset. 21 As Bcy1 is the common regulatory subunit of all three catalytic PKA-subunits (Tpk1, Tpk2 and Tpk3), 22 it is conceivable that these sites form part of a feedback loop regulating PKA activity. Indeed, S145 23
has previously been reported as a PKA target as part of its negative feedback mechanism (46). The 24 same study identified S145 as the by far major target of PKA on Bcy1, which is consistent with this 25 site being the only RRxS/T-site in the protein. The other sites determined in our study may therefore 26 be targets of other kinases or weaker PKA-targets. 27 We did not detect any peptides on phospho-diesterase Pde1, which has been reported as another 28 component of cAMP-signalling that is a target PKA (47). Instead, S534 and S631 on Ras GTPase 29 activating protein Ira2 were significantly altered in their phosphorylation state upon PKA inhibition 30
and may therefore constitute a so far unknown feedback mechanism of PKA. 31
The reason for the clustering of phosphorylation-sites on AGC-kinase targets is not well understood 32
in most cases, but it may allow generating switch-like responses similarly to other kinase targets 33 (48). In any case, the discovery of multiple sites within certain proteins, which are affected by kinase 34 inhibition suggests that the function of these proteins is regulated by said kinase. 35
Phospho-sites within kinase consensus motifs 36 As described above, we observed a strong enrichment of arginine in the -3 position of phospho-37 peptides significantly hypo-phosphorylated upon inhibition of any of the kinases tested. Indeed, of 38 the 484 identified phospho-sites within a RxxS/T-motif, 117 were significantly (Padj < 0.05) hypo-39 phosphorylated in at least one of the datasets. Since this is consistent with previously reported 40 kinase consensus motifs (RRxS/T for Sch9 and PKA and RxRxxS/T for Ypk1) (37,45), we argued that 41 the corresponding sites may constitute potential direct kinase substrates. We asked if these 42 potential direct targets are shared between kinases tested or specific to individual kinases. 43
Similar to the data on all hypo-phosphorylated sites, the vast majority of RxxS/T-sites in the PKA or 44
Sch9 dataset were also part of the PKA+Sch9 set. Not all of these sites overlapped between the PKA 45 and Sch9 samples, indicating that they may be targets of only one of the two kinases or that 1 inhibition of one kinase targeting a site is compensated by the second kinase (Fig. 3A) . 2 While 45 RxxS/T-sites were uniquely affected by Ypk1-inhibition, 36 sites were also hypo-3 phosphorylated in at least one other dataset. As the Ypk1 consensus motif is considered to be 4 distinct from the PKA/Sch9 motif, we asked if this overlap mainly comprised sites within RRxS/T-or 5
RxRxxS/T-motifs. 6 We therefore evaluated the overlap of significantly hypo-phosphorylated RxRxxS/T and RRxS/T sites 7 between datasets ( Fig. 3B and 3C ). As expected, the majority of RxRxxS/T-sites (twenty of 24) were 8
unique to the Ypk1-set. Consequently, sites with an RxRxxS/T-motif do not explain the overlap of 9
RxxS/T-sites between the Ypk1 and the other three datasets. On the other hand, 31 RRxS/T-sites were hypo-phosphorylated in the Ypk1 dataset, of which 24 18
overlapped with at least one of the other sets ( Fig. 3C ). Among these 31 sites only four were 19 simultaneously in an RxRxxS/T-motif (i.e. RxRRxS). Assuming these sites are indeed direct Ypk1 20 targets, the previously defined Ypk1 consensus motif of RxRxxS/T may need to be reconsidered. 21 We next asked if the RRxS/T-sites that are potential Ypk1 targets had any other sequence 22 characteristics close to the phospho-site, but no obvious amino acid enrichments at other positions 23 within five residues from the phospho-site were observed (Fig. S7 ). 24 25 Following the unanticipated observation that Ypk1 affects the phosphorylation state of sites 26 presumed to be PKA-and/or Sch9-targets based on our results and their sequence context, we next 27
aimed to validate this observation on a selected candidate protein. 28 29 Nth1 phosphorylation of S83 is positively regulated by PKA and Ypk1
30
Our phospho-proteomics assay detected a phospho-peptide (81RGSEDDTYSSSQGNR95 + phos) of 31 neutral trehalase Nth1 with potential phosphorylation at S83 or T87 (or a mix of both), down-32 regulated with a fold-change (FC) of 0.6 (p = 0.007), 0.5 (p = 0.009) and 0.3 (p = 4x 10 -5 ) upon Ypk1, 33
PKA and PKA+Sch9 inhibition respectively. A second phospho-peptide of Nth1 mapping to S60 34 (58TMSVFDNVSPFKK70 + phos) exhibited significant down-regulation upon Ypk1 (FC = 0.4; p = 0.0004), 35 PKA (FC = 0.5; p = 0.01) and PKA+Sch9 (FC = 0.5; p = 0.02) inhibition. 36
Nth1 is a commonly cited model-substrate of PKA and its trehalase activity is increased by PKA-37 dependent phosphorylation of its N-terminal tail (29, 49, 50) . 38
In contrast, while Ypk1 had previously been shown to regulate metabolic functions, including of 1 enzymes influencing the levels of the osmo-protective metabolite glycerol, the regulation of the 2 major thermo-protective metabolite trehalose has not been reported (51,52). To validate our 3 phospho-proteomics results we asked whether Ypk1-inhibition would alter the phosphorylation of 4
an RRxS-site (S83) on Nth1, whose phosphorylation had previously been attributed to PKA (25,50). 5 6 Fig. 4 : Western blotting demonstrates dephosphorylation of Nth1 S83 upon inhibition of PKA, 7
PKA+Ypk1 and Ypk1. 8 Strains wt as , pka as , pka as +ypk1 as and ypk1 as harbouring endogenously C-terminally 3xFLAG tagged 9
Nth1, the corresponding isogenic wt strain with 3xFLAG-tagged nth1-S20A,S21A,T58A,S60A,S83A 10
(wt as nth1-5A-3xFLAG) and untagged isogenic wt strain (wt as ) were treated with DMSO or 500 nM 11
1NM-PP1 for 15 min. Eluates from immuno-precipitates with an anti-FLAG antibody were probed 12 with antibodies against S83p and against the FLAG-tag. 13
14
We evaluated the phosphorylation of this site on endogenously 3xFLAG-tagged Nth1 after immuno-15 affinity purification by western blotting with an antibody against phosphorylated S83 (S83p) (25) . 16 Indeed, the signal was reduced upon 1NM-PP1 treatment of strains harbouring either analog-17
sensitive Ypk1 or PKA (Fig. 4) . Importantly, no signal remained in the absence of both enzymatic 18
functions. We also tested the phosphorylation of S83 upon Ypk1, PKA and Ypk1+PKA inhibition in an 19 independent experiment using a targeted proteomics assay. The results closely agreed with the ones 20 obtained by western blotting and confirmed that S83, and not T87, was the phosphorylated residue 21 ( Fig. 5; Fig. S8 ). 22 These findings validate the effect of Ypk1 on phosphorylation of a site located within an RRxS-motif 23 and therefore not assumed to be a direct Ypk1 target based on its previously reported consensus 24 motif (45). S83p. Indicated strains were treated with DMSO (grey) or 500 nM 1NM-PP1 (orange) for 15 5 min. Bars represent averages from three replicates and errorbars represent standard error 6 of the mean. Asterisks indicate significant fold changes at p-values less than 0.05. 7 8 Nth1 is activated in a PKA-and Ypk1-dependent manner 9
It has been previously reported that the PKA-dependent phosphorylation of the N-terminal tail of 10
Nth1 stimulates the enzyme`s trehalase activity (24, 25, 29) . Based on our results of Ypk1-dependent 11
phosphorylation of Nth1 we asked if Ypk1 would also regulate Nth1 activity. 12
For this we again compared wt as , pka as and ypk1 as strains treated for 15 min with 1NM-PP1 with 13 mock-treated controls and assessed trehalase activity by a method similar to the one described by 14
De Virgilio, 1991 (53) . 15 We employed a nth1Δ strain as a control in this experiment. For this strain no detectable trehalase 16 activity could be observed ( Fig. S9A and S9B) indicating that Nth1 is the only trehalase active under 17 these conditions. Note that acidic trehalase is not expected to be active at the neutral pH used for 18 this assay. We observed that trehalase activity was strongly reduced in the pka as , and somewhat also 19 in the ypk1 as strain, even in the absence of 1NM-PP1, indicating the hypomorphic nature of these 20 strains ( Fig. S9A and S9B ). Importantly, a significant reduction of trehalase activity in both analog-21 sensitive strains was observed upon 1NM-PP1 addition relative to mock treated controls (p = 6x 10 -6 22 and 1x 10 -5 respectively; Fig. 6, Fig. S9A and S9B ). This indicates that, as for PKA, Nth1-activity was 23 positively regulated in a Ypk1-dependent manner. 24 It can therefore be envisioned that stresses inactivating Ypk1 cause trehalose accumulation. Similarly 1 to PKA, return to favourable growth conditions and re-activation of Ypk1 may lead to trehalose 2 degradation by Nth1. Barplot depicting trehalse activity of 1NM-PP1 treated wt as , pka as and ypk as strains relative to activity 7 of corresponding DMSO-treated strains. Strains were in exponential growth phase and treatment 8 was for 15 minutes. Error-bars depict standard deviation of six replicates. Reduction of relative 9 trehalase acitivity in pka as and ypk1 as strains is significant with p = 6x 10 -6 and p = 1x 10 -5 respectively. 10 11 1 Previous studies on AGC-kinase functions 2
DISCUSSION
In this study we investigated the targets of three major growth-regulatory AGC-kinases in S. 3 cerevisiae, PKA (Tpk1, Tpk2, Tpk3), Sch9 and Ypk1. For this purpose we employed analog-sensitive 4 versions of these kinases in combination with phospho-proteomics. A ypk1Δ ypk2Δ double-and 5 tpk1Δ tpk2Δ tpk3Δ triple-deletion renders cells inviable and deletion of SCH9 leads to severe 6 phenotypic effects, demonstrating the important roles that these kinases perform (6, 8, 16) . A 7 previous large scale phospho-proteomics investigation of strains in which individual kinases had 8 been disrupted included tpk1Δ, tpk2Δ, tpk3Δ, ypk1Δ and ypk2Δ strains (22) . Of necessity, this 9
approach precluded the study of strains harbouring deletions of essential paralogs. A further 10 disadvantage of using deletion strains for studying an enzyme is that such strains inevitably adapt in 11 ways that often mask effects on direct targets. 12
Analog-sensitive strains of AGC-kinases have been described previously, but not to determine the 13 effect of their inhibition on global phosphorylation changes (17, 30, 54) . We reasoned that the acute 14 inhibition of kinases via a chemical genetics strategy in combination with a direct readout of 15 phosphorylation changes should enable us to increase our understanding of signalling downstream 16 of these kinases and in particular identify novel direct targets. 17
Interplay between Sch9-and PKA-signalling 18 There is ample genetic evidence for a close link between PKA-and Sch9-dependent signalling (3): 19
In fact, Sch9 was identified as a high copy suppressor of a temperature sensitive mutation in the 20
Ras2-guanine nucleotide exchange factor Cdc25 (6). On the flip-side, Sch9 exhibits synthetic lethality 21 with components of the PKA-pathway, Gpr1, Gpa2 and Ras2 (55-57). Signalling through the PKA-22
pathway represses stress-protective activities of Yak1 and Msn2/4 and G0-entry via Rim15. The 23 subsequent heat-shock sensitivity of an activating mutation in GPA2 is suppressed by deletion of 24 SCH9 (58). 25 Consistently, we observed a strong overlap of phospho-sites affected by PKA-and Sch9-inhibition. 26 Further, a high number of sites detected only upon simultaneous inhibition of both kinases may 27 comprise further shared sites for which the activity of one kinase masks the inhibition of the other. 28 The consensus sequence detected for both kinases closely resembles their established RRxS/T-motif 29 (37,59,60). 30
These observations pose fundamental questions for future research: Is the considerable overlap 31 between sites affected by PKA and Sch9 inhibition due to cross-talk between the two signalling 32 pathways or due to shared targets of the two kinases? In case of targets unique to one of the 33 kinases, how is this selectivity established, considering the high similarity of the PKA-and Sch9-34 consensus motifs? The data provided in this study serves as a starting point to answer these 35 questions. 36 Interplay between Ypk1-and PKA/Sch9-signalling 37 While evidence for an overlap between PKA-and TORC1-Sch9-signalling had been reported, TORC2-38
Ypk1-signalling is considered to be distinct from the former two pathways. Despite shared subunits 39 between the TOR-complexes, TORC1 is believed to mainly respond to nutritional cues while TORC2 40 presumably receives its input primarily from the cell membrane (61). 41
Several findings in this study tie Ypk1 much more closely to PKA and Sch9 than we previously 42 assumed: while many phospho-peptides were affected uniquely upon Ypk1 inhibition, a surprisingly 43 high number overlapped with the other datasets. Secondly, while the Ypk1 consensus motif derived 44 in this study was consistent with the previously reported RxRxxS/T-motif, a clear enrichment of 45 arginine in the -2 position could be observed. Closer investigation of basophilic sites hypo-1 phosphorylated upon Ypk1 inhibition revealed two nearly mutually exclusive sets of Ypk1 targets: 2 one set of sites associated with the RxRxxS/T-motif and almost uniquely affected by Ypk1-inhibition 3 and the other of sites associated with the RRxS/T-motif and largely shared with at least one other 4
kinase. These observations suggest that Ypk1 recognizes two related, but distinct motifs. 5 Alternatively, Ypk1 may regulate these sites indirectly through an RRxS/T-specific kinase. 6
Kinase target motifs 7 The commonly cited Ypk1 target motif is RxRxxS/T (with an additional preference for a hydrophobic 8 residue in the +1 position) and was defined by the Thorner lab based on nine bona fide Ypk1 target 9 sites on five proteins and previously published in vitro assays on synthetic peptides (46). This 10 resembles the consensus motif of the presumed human homolog of Ypk1/2, SGK (21) . It is 11 interesting to note that, while one of the in vitro studies to define the Ypk1 target motif did not test 12 peptides containing the RRxS/T-sequence (21) , the second reported a Ypk1 motif similar to our 13 study: while arginine in the -3 position was most strongly enriched, a similar prevalence of arginine 14 in -5 and -2 was also observed (37). Parenthetically, for Ypk2 the target sequence even more closely 15
resembled an RRxS/T-motif. Collectively, these results suggest that Ypk1 also recognizes RRxS/T-16 motifs besides RxRxxS/T. 17 After the initial definition of the Ypk1 consensus motif (38) twelve further sites on six proteins were 18 identified, which all reside in RxRxxS/T-motifs (38,38,41,62). However, the presence of this motif in 19
each case constituted a criterion in the search for new Ypk1 sites, biasing the selection. 20 It should also be noted that the assays performed in our study targeted Ypk1 during conditions of 21 basal activity rather than in contexts where it is highly activated. It may be speculated that full 22 activation of Ypk1 leads to a change in its substrate preference. This idea is particularly intriguing as 23 distinct phosphorylation steps by Pkh1/2 and TORC2 may lead to partial and full activation of Ypk1 24 (14,21). 25
In contrast to Ypk1, the sequence motif for sites hypo-phosphorylated upon PKA-inhibition closely 26 agrees with the previously reported PKA-consensus motif. Similarly, our Sch9-motif is in agreement 27 with a motif previously defined by peptide-array (37) and with the fact that bona fide Sch9 target 28 sites are generally in an RRxS/T-motif (2,32,42). 29
Regulation of trehalose metabolism by Ypk1
30
We further investigated the connection between PKA-and Ypk1-signalling by choosing neutral 31 trehalase Nth1 as an example. The phosphorylation of its N-terminal tail (S20, S21, S60 and S83) by 32 PKA has been previously reported (25, 29, 50) . It has been suggested that this phosphorylation leads 33 to the activation of its trehalase activity, mainly through the binding of 14-3-3 proteins to 34 phosphorylated S60 and S83 (49,50). We here showed that Nth1 phosphorylation and activity is also 35 diminished by Ypk1 inhibition in vivo, therefore establishing a connection betweenTORC2-signalling 36 and storage carbohydrate metabolism. 37
Only few Ypk1 targets are currently known. Regulation of trehalose metabolism may therefore be a 38 so far overlooked TORC2-dependent stress response. If this regulation is indeed via direct 39 phosphorylation of the N-terminal tail of Nth1 by Ypk1, remains to be determined. The fact that two 40 of the presumed regulatory sites, S20 and S60, reside within an RxRxxS/T-sequence, the preferred 41
Ypk1 target motif, argues in favour of this possibility, regardless of if Ypk1 can also phosphorylate 42
RRxS/T-sites. 43
Further phospho-sites on trehalose-6-P synthase/phosphatase subunits Tsl1, Tps2 and Tps3 were 44 affected by Ypk1 inhibition and may provide further ways of TORC2-signalling modulating this 45 metabolic pathway. 46
The TORC2-dependent regulation of endocytosis in contrast is well-established, however 1 mechanistically not well understood (33). Our data provide an extensive list of Ypk1-regulated 2 phospho-proteins involved at several steps of endocytosis. It will be interesting to map the location 3 of these proteins in the TORC2-Ypk1 pathway and to define phenotypic consequences of site-specific 4 mutants of the corresponding phospho-sites. 5
Finally, we reported phospho-sites affected by the inhibition of AGC-kinases on proteins that had not 6 been previously linked to signalling through these kinases. Based on the close match of sequence 7 motifs derived from these sites and the reported consensus motifs of the kinases it is likely that we 8
detected several direct kinase targets, setting the stage for future focused studies. 9
METHODS
10
Yeast cultures and assays 11 Saccharomyces cerevisiae strains used in this study are listed in Tab. S4. Strains were constructed 12 using standard yeast genetic manipulation (63). 13
Label-free phospho-proteomics 14 Three replicates each of DMSO-and 1NM-PP1-(Merck, Darmstadt, Germany) treated sch9 as , pka as , 15
pka as +sch9 as and ypk1 as cultures were prepared for label-free phospho-proteomics as previously 16
described (32) . In brief, all cultures were diluted to OD 0.2 and grown to exponential phase (OD 0.7-17 0.8). Each strain was treated with 500 nM 1NM-PP1 or DMSO for 15 minutes after which ice cold 18
100% TCA was added to a final concentration of 6%. The samples were incubated on ice for 30 19 minutes. After centrifugation the cells were washed twice with acetone and kept at -70 o C. 20 Cell pellets were suspended in a buffer consisting of 8 M urea, 50 mM ammonium bicarbonate, and 21 5 mM EDTA, then lysed by beat beating. For each biological replicate, 3 mg protein were reduced 22 using 5 mM TCEP, alkylated in 10 mM iodoacetamide, and digested overnight with trypsin (1:125 23 w/w). Reverse phase chromatography was used to purify samples before phospho-peptide 24 enrichment, which was performed with titanium dioxide resin (1.25 mg resin for each sample) (22) . 25 Isolated phospho-peptides were analyzed on an LTQ-Obritrap XL mass spectrometer (Thermo  26 Scientific, Basel, Switzerland). A 90 minute gradient, starting with 3% and ending with 23% 27
acetonitrile, was used for liquid chromatography elution. The 4 most intense ions detected in each 28 MS1 measurement were selected for MS2 fragmentation. 29 30
Data analysis 31
The 30 .raw files were processed with the MaxQuant software, which uses the Andomeda MS/MS 32 spectrum search engine (64,65). The following search settings were used: enzyme was Trypsin/P 33 with 2 allowed missed cleavages. The first search tolerance was set to 20 ppm and the main search 34 tolerance to 4.5 ppm. Phosphorylation of serine, threonine and tyrosine residues, oxidation of 35 methionine, acetylation of protein N-termini and deamidation of asparagine and glutamine were 36 used as variable modifications (maximal 5 modifications per peptide). Carbamidomethylation of 37 cysteine was used as fixed modification. The SGD yeast protein database 38 (https://downloads.yeastgenome.org/sequence/S288C_reference/orf_protein/ 39 orf_trans_all.fasta.gz) from 2015-01-13 was used to match the spectra. Finally, a peptide and 40 modification site FDR of 0.01 was applied to filter peptide spectrum matches (PSM). Contaminants 41 and decoys were subsequently removed from the results. 42 43
The MaxQuant result tables (msms.txt for PSMs and positioning information, 44 modificationSpecificPeptides.txt for intensity values) were imported into the R statistical 45 environment to perform missing value imputation and intensity normalization. Only peptides 46 containing at least one phosphorylation were retained, together with all possible positions of the 1 phosphorylation and their respective scores. All intensity values were log2 transformed. 2 3 Fig. S10A shows the occurrence of missing values across the 3000+ phospho-peptides revealing that 4 certain peptides and certain MS-runs are more prone to missing values. An example of a peptide 5
with missing values can be seen in Fig. S10B , where all Sch9/PKA-1NM-PP1 values of the peptide 6 HSS(ph)PDPYGINDKFFDLEK and one Sch9 and one PKA value are missing. In the sibling peptide (see 7 below) HSS(ph)PDPYGINDK with clearly higher MS1 intensities all values are present (Fig. S10C ). This 8
shows that even if all 3 replicates values are missing, one cannot conclude absence of the 9 corresponding peptide, but these missing values are most likely artefacts inherent to MS1 based 10 quantitation. Phospho-peptides with no missing values in 3 replicates have stronger average MS1 11 signal intensities compared to peptides with missing values (Fig. S10D ). If only one value out of 3 12
replicate values is missing, the 2 remaining positive replicate values can be used to estimate or 13 impute the missing values (see below). However, if 2 or 3 values are missing, imputation becomes 14 more error prone and can easily lead to false positives, when searching for peptides of differential 15
abundance. Therefore, we only retained peptides with maximally one missing value per 3 replicates. 16 67.3% of all phospho-peptides fall in this category (Fig. S10E ). 17 18 We imputed a missing log2-transformed intensity value IP,S,i of peptide P in replicate i of sample S by 19 20 , , = , , + ( , )
(1) 21 22 where αP,S,i is the mean of the 2 non-missing values of peptide P in sample S and ( , ) is a 23
Gaussian error term with mean μ and standard deviation σ. In order to estimate this error term, we 24 first need the notion of sibling peptides. Two peptides are called siblings if the sequence of one 25 peptide is a N/C-terminal extension of the sequence of the other one (i.e. they differ by a missed 26 cleavage) and if they carry the same modifications. It is unlikely that the sample condition has a 27 direct influence on the trypsin cleavage and it can be expected that two sibling peptides have similar 28 expression profiles. 29 The imputation parameters μ and σ are then estimated using the sibling peptides present in the 30
MaxQuant results: for each peptide P with a missing value in replicate i in sample S, we searched for 31 sibling peptides P' of P with no missing values in the 3 replicates of sample S. Then we calculated the 32 difference between the IP',S,i and αP',S,i and used all these differences to estimate μ and σ. The result 33
shown in Fig. S10F reveals that the missing values are on average slightly, but significantly lower 34 than the average of the 2 non-missing values (t-test p-value of 0.003), a small bias that we took into 35 account in the imputation Equation 1). 36
After missing value imputation, the R package limma (66) was used for intensity normalization. First 37 the normalizeBetweenArrays R-function was used to equalize the log2-intensity distributions in all 30 38
LC-MS runs. The lmFit function was used to remove eventual batch effects present in the 10 39 samples. The empirical Bayes (eBayes) method was the applied to compare the 1NM-PP1 treated to 40 the control (DMSO) samples for each strain and to calculate fold-changes and p-values adjusted for 41 multiple testing (FDR adjustment). 42 43
Generation of sequence logos 44
For each phospho-peptide that exhibited a change upon treatment with an adjusted p-value of less 45 than 0.05 the sequence from -5 to +5 amino acids from each of the phospho-sites localized on the 46 peptide was extracted. In case of ambiguity between isoforms with different phospo-localizations, 47 the peptide with the best localization score was chosen. If a phospho-site was represented by 1 several peptides, the sequence surrounding the site was listed only once. This was performed 2 individually for each strain for hyper-and hypo-phosphorylated peptides and the union of both. 3 Sequence logos were generated with pLogo using all quantified phospho-peptides as a background 4 (67). 5 6 Gene ontology analysis 7
For GO-analysis the systematic gene names of proteins harbouring phospho-sites significantly 8
changing upon kinase inhibition with an adjusted p-value below 0.05 were used as a foreground and 9
harbouring any quantified phospho-site as a background. The analysis was performed using the ' GO 10 Term Finder' tool at the Saccharomyces Genome Database at a p-value of 0.05 with FDR calculation 11 enabled (68). 12
The network of proteins associated with GO-term "Endocytosis" in the Ypk1-dataset was displayed 13
the STRING-database tool at default parameters (69). 14 15 Parallel Reaction Monitoring 16 Samples for targeted proteomics by Parallel Reaction Monitoring (PRM) were prepared from 250 µg 17 of protein in a similar manner as for label-free phospho-proteomics, with the exception that a 18 mixture of magnetic TiO2, ZrO2 and Ti(IV)-IMAC beads (15 µl each; ReSyn Biosciences, Edenvale, 19
South Africa) were used for phospho-peptide enrichment, essentially following the manufacturer`s 20 instructions. 21 Data acquisition was performed on an Orbitrap Fusion Tribrid mass spectrometer coupled to an 22 nLC1000 uHPLC. Peptides were separated on a 25 cm EASY-spray column (Thermo Scientific) with a 23 30 min gradient from 3 to 25% acetonitrile, 0.1% formic acid vs. 0.1% formic acid in water. MS-scans 24
were acquired at 60 000 resolution, with an ion target of 4x 10 5 and maximum injection time of 118 25 ms. Targeted MS/MS employing higher energy collisional dissociation on 9 selected precursors 26
representing Nth1 phospho-peptides and targeted single ion monitoring on two precursors were 27 each acquired at a resolution of 60 000 with an ion target of 4x 10 5 and maximum injection time of 28 200 ms. 29 For data analysis in Skyline 4.2.0.19072 we employed spectral libraries from previously generated 30 data-dependent acquisition and filtered for seven b-or y-ions from ion 3 to last ion (70). 31
The extracted total areas were normalized to the total ion current area of the corresponding sample 32 and an intensity-weighted mean was calculated for cases in which phospho-sites were represented 33 by several precursors. The significance of changes between DMSO-and 1NM-PP1 treated samples 34 was evaluated using a two-sided Student`s t-test. 35 36 Spot assays 37 Yeast strains were inoculated in YPD (pH 5.6) and incubated at 30 o C and 120 rpm overnight, diluted 38 to OD = 0.1 the next morning and again to 0.0002 in the evening with incubation under the same 39
conditions. Once an OD of about 0.8 was reached cultures were diluted to OD 0.08 and further in a 40 10x dilution series in the same medium. The lysate was incubated with the beads at 4 o C for 4 h, then washed four times with IP-buffer. 5 Proteins were eluted in 15 µl Laemmli-buffer at 65 o C for 10 min, then in further 15 µl Laemmli-buffer 6
at 95 o C for 5 min. 7
The eluates from both steps were combined and resolved on a 7.5% SDS-PAGE gel. Proteins were 8 transferred to a nitrocellulose membrane using an iBlot2 system, blocked in 5% BSA in PBS for 1 h. 9
The membrane was incubated with primary antibodies (1:1000 mouse anti-FLAG (Merck) and 1:100 10 rabbit anti-Nth1-S21p or anti-Nth1-S83p, kind gifts from the Thevelein lab (25) Samples were thawed at 30 o C in a thermomixer at 1400 rpm, centrifuged for 1 min at 12 000 g and 31 the pellet washed in 1 ml of cold 0.2 M tricine pH 7.0 (1 min, 12 000 g, 4 o C). Pellets were 32 resuspended in 1 ml of cold 0.2 M tricine (pH 7.0) and transferred into the wells of a deep-well 96-33
well plate on ice. The plate was spun for 5 min at maximum speed and 4 o C, supernatants removed 34 and pellets resuspended in 320 μl 62.5 mM tricine pH 7.0, 250 μM CaCl2 containing protease-and 35 phosphatase-inhibitors. A well which did not contain a yeast pellet was used as blank. The plate and 36 0.5 M trehalose were equilibrated to 30 o C for 5 min before 80 μl of 0.5 M trehalose were added to 37 each sample and incubation at 30 o C. After 10, 20, 30 and 40 min a 25 μl aliquot of each sample was 38 transferred into PCR-stripes and heated to 98 o C for at least 3 min. 39 The samples were cooled to room temperature and cell debris spun down briefly. The amount of 40 glucose in the supernatants was determined using a Glucose-Oxidase/Peroxidase kit (Merck) using 5 41 μl input in a 150 μl reaction volume. 42 The amount of glucose generated (= 2x amount of trehalose degraded) was determined against a 43 glucose standard and the blank value subtracted from each sample. The slope of the curve of 44 trehalose degraded vs. time after trehalose addition with y-intercept of zero was determined as a 45 measure for trehalase activity. 46
This activity was normalized to the protein level determined by BCA assay (Thermo Scientific) after 47 spinning the remaining samples and bead beating of the resulting pellets in 400 μl 1% SDS, 6 M urea 48 in 25 mM Tris (pH 6.8). The trehalase activity per protein content of the pka as and ypk1 as strains were 1 each compared to that of the wt as strain using a two-sided, unpaired Student`s t-test. 2 3 Acknowledgements 4
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